Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
9.76
-0.10 (-1.01%)
Dec 24, 2025, 4:00 PM EST
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.34 billion as of December 26, 2025. Its market cap has increased by 9.02% in one year.
Market Cap
2.34B
Enterprise Value
1.89B
Revenue
1.08B
Ranking
n/a
PE Ratio
6.09
Stock Price
$9.76
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.34B, an increase of 34,364.55%. That is a compound annual growth rate of 24.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 2.34B | 12.92% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | 1.80B | 116.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 730.42M |
| Elite Pharmaceuticals | 515.58M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 390.29M |
| CytoDyn | 359.24M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |